CCO Practice Guidelines
|
CATEGORY
|
REGIMEN CODE
|
NAME OF DRUGS USED IN THERAPY
|
|
Core
|
IE-VAC
|
Ifosfamide-Etoposide-Vincristine-ADRIAMYCIN
®
(Doxorubicin)-Cyclophosphamide
|
|
IFOSDOXO
|
Ifosfamide-Doxorubicin
|
|
IFOSETOP
|
Ifosfamide-Etoposide
|
|
Local
|
TOPOCYCLO
|
Topotecan-Cyclophosphamide
|
|
VActC
|
Vincristine-Actinomycin (Dactinomycin)-Cyclophosphamide
|
|
Archive
|
CYVAD
|
Cyclophosphamide-Vincristine-ADRIAMYCIN
®
(Doxorubicin)
|
|
VAC-XRT
|
Vincristine-ADRIAMYCIN
®
(Doxorubicin)-Cyclophosphamide
|
Ewing's
|
CATEGORY
|
REGIMEN CODE
|
NAME OF DRUGS USED IN THERAPY
|
|
Core
|
CISPDOXO
|
Cisplatin-Doxorubicin
|
| CISPDOXO-HDMTX
| Methotrexate (high dose)-Cisplatin-Doxorubicin
|
| HDMTX
| Methotrexate (high dose) |
|
IFOS
|
Ifosfamide
|
|
IFOSETOP
|
Ifosfamide-Etoposide
|
|
Archive
|
DOXODTIC
|
Doxorubicin-DTIC (Dacarbazine)
|
|
MAID
|
Mesna-ADRIAMYCIN
®
(Doxorubicin)-Ifosfamide-Dacarbazine
|
| | T-10
| Methotrexate-Bleomycin-Cyclophosphamide-Dactinomycin-Doxorubicin
|
Osteogenic
|
CATEGORY
|
REGIMEN CODE
|
NAME OF DRUGS USED IN THERAPY
|
|
Core
|
DOXO
|
Doxorubicin
|
|
DTICDOXO-DESMOID
|
DTIC (Dacarbazine)-Doxorubicin
|
|
IFOS
|
Ifosfamide
|
|
IFOSDOXO
|
Ifosfamide-Doxorubicin
|
|
VINBMTX-DESMOID
|
Vinblastin-MTX (Methotrexate)
|
|
VINOMTX-DESMOID
|
Vinorelbine-MTX (Methotrexate)
|
|
Local
|
CISPDOXO
|
Cisplatin-Doxorubicin
|
|
DOXODTIC
|
Doxorubicin-DTIC (Dacarbazine)
|
|
MAID
|
Mesna-ADRIAMYCIN
®
(Doxorubicin)-Ifosfamide-Dacarbazine
|
|
PACLI
|
Paclitaxel
|
|
Emergent
|
GEM-DOCE
|
Gemcitabine-Docetaxel
|
| |
IFOSEPI
|
Ifosfamide-Epirubicin
|
|
IMATINIB
|
Imatinib Mesylate
|
|
Archive
|
AC
|
ADRIAMYCIN
®
(Doxorubicin)-Cyclophosphamide
|
|
CYVADIC
|
Cyclophosphamide-Vincristin-ADRIAMYCIN
®
(Doxorubicin)-DTIC (Dacarbazine)
|
|
DTIC
|
DTIC (Dacarbazine)
|
|
EPI
|
Epirubicin
|
|
ID-DD
|
Ifosfamide-Doxorubicin-Dacarbazine
|
Soft Tissue
|
|
Last modified: Tue, May 04, 2010